FY2024 Earnings Estimate for RNAC Issued By Leerink Partnrs
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Leerink Partnrs lifted their FY2024 earnings per share (EPS) estimates for shares of Cartesian Therapeutics in a research note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings per share of $4.85 for the year, up […]
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Free Report) – Leerink Partnrs lifted their FY2024 earnings per share (EPS) estimates for shares of Cartesian Therapeutics in a research note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings per share of $4.85 for the year, up […]
